| Quantity: | |
|---|---|
This product contains inactivated Clostridium perfringens Type A and Type C strains.
Yellowish-brown powder.
This vaccine is used for immunization of sows in late gestation. Newborn piglets obtain passive immunity via colostrum to prevent piglet enterotoxemia caused by Clostridium perfringens Type A and Type C infections.
Administer via intramuscular injection. Dilute the vaccine with 20% aluminum hydroxide gel and normal saline solution according to the specified doses on the bottle label and shake thoroughly. Immunize pregnant sows twice before farrowing, once at 35–40 days' prenatally and once at 10–15 days' prenatally, with 1 dose (2.0 mL) per vaccination.
10 doses/vial
Store at 2–8 °C. Shelf life: 36 months from the date of manufacture.
For use only under veterinary supervision.
Dual-strain full coverage for precise prevention:Adopts bivalent inactivated formula containing type A and Type C Clostridium perfringens, covering two major pathogenic strains. It effectively prevents piglet enterotoxemia and solves stubborn diarrhea such as piglet red dysentery and necrotizing enteritis.
Maternal immunization for full piglet protection:Standard immunization of late-gestation sows produces high-level antibodies, which are transferred to newborn piglets via colostrum. It protects piglets during the high-risk lactation period and reduces the incidence and mortality of clostridial diseases from the source.
Scientific dual immunization for stable antibody protection: The two-dose immunization procedure (primary vaccination 35–40 days before delivery and booster 10–15 days before delivery) stimulates high-concentration and stable antibodies, ensuring continuous and effective protection for suckling piglets.
Safe inactivated technology suitable for pregnant sows: Advanced fully inactivated technology ensures no pathogenicity and zero stress risk. Safe for immunization of healthy pregnant sows without affecting gestation and fetal development.
Standard dilution process for easy implementation: Matched with 20% aluminum hydroxide saline diluent for uniform vaccination. The standardized specification fits regular sow mass immunization procedures with simple operation and high practicability.
Ultra-long shelf life with high cost performance: Storable under conventional 2～8℃ cold chain with no freezing required. The 36-month ultra-long validity period greatly extends inventory cycle and reduces farm stocking and replacement costs.
A: This is a type A and C bivalent inactivated vaccine for piglet Clostridium perfringens disease, a non-prescription veterinary drug. It is mainly used to prevent piglet enterotoxemia and neonatal red dysentery caused by Clostridium perfringens type A and C.
Q: What is the immune protection principle of the vaccine? What are its protective advantages?
A: Late-gestation sows produce specific antibodies after vaccination. Newborn piglets obtain passive immunity through colostrum, covering the high-risk diarrhea period during lactation and reducing piglet morbidity and mortality fundamentally.
Q: What are the key precautions for vaccine dilution and use?
A: Dilute with special 20% aluminum hydroxide saline and shake well after dilution. Use up the diluted vaccine on the same day. The supporting diluent is prohibited from freezing to avoid affecting vaccine efficacy.
Q: What are the immunization procedure, inoculation method and dosage?
A: Intramuscular injection after dilution with 20% aluminum hydroxide saline. Healthy late-gestation sows receive primary vaccination 35–40 days before delivery and booster vaccination 10–15 days before delivery, 1 dose (2.0ml) each time.
Q: What are the storage conditions, shelf life and specifications?
A: Store at 2～8℃ away from light with a 36-month ultra-long shelf life. The specification is 10 doses per bottle, suitable for centralized immunization of sows with high cost performance.
Q: How to dispose of wastes after vaccine use?
A: Used vaccine bottles, injection appliances and residual vaccine must be collected and disposed of harmlessly to avoid biosafety risks.
